Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study

Osteogenesis imperfecta (OI) is an hereditary disease characterized by low bone mass, increased bone fragility, short stature, and skeletal deformities, few treatment options are currently available. Neridronate is an amino-bisphosphonate, licensed in Italy for the treatment of OI and Paget’s diseas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cases Miner Bone Metab
Hlavní autoři: Leali, Paolo Tranquilli, Balsano, Massimo, Maestretti, Gianluca, Brusoni, Matteo, Amorese, Veronica, Ciurlia, Emanuele, Andreozzi, Matteo, Caggiari, Gianfilippo, Doria, Carlo
Médium: Artigo
Jazyk:Inglês
Vydáno: CIC Edizioni Internazionali 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726200/
https://ncbi.nlm.nih.gov/pubmed/29263724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11138/ccmbm/2017.14.1.153
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky